Abstract
Lyme disease is a zoonosis caused by infection with Borrelia burgdorferi (Bb). A great amount of research has attempted to elucidate the mechanisms by which Bb causes inflammation and chronic symptomatology in some patients. Patients often seek unconventional treatments that lack scientific evidence, as medical care is unable to effectively explain and treat their illness. Bb-DNA can persist for long periods of time in some individuals, even after antibiotic therapy. Herein, scientific rationale is presented for a new therapeutic approach against remaining bacterial DNA, and/or increasing the ability of human macrophages to remove extracellular Bb DNA.
| Original language | English |
|---|---|
| Pages (from-to) | 459-463 |
| Number of pages | 5 |
| Journal | Microbes and Infection |
| Volume | 19 |
| Issue number | 9-10 |
| DOIs | |
| State | Published - Sep 1 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 Institut Pasteur
ASJC Scopus Subject Areas
- Microbiology
- Immunology
- Infectious Diseases
Keywords
- Antimicrobial peptides
- Borrelia burgdorferi
- DNA persistence
- Lyme disease
- Post-treatment Lyme syndrome
- TLR9
Fingerprint
Dive into the research topics of 'Doctor says you are cured, but you still feel the pain. Borrelia DNA persistence in Lyme disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS